BCRP2 and breast cancer: To avoid confusion, we will be using henceforth BCRP2 as the human ABCG2, which was first isolated from multidrug resistant human breast cancer cells where it mediates resistance to the widely used drugs in breast cancer treatment anthracyclines [65].